Yes, gene editing has shown promise as a potential treatment for cancer. One approach involves editing the patient's own immune cells to better recognize and attack cancer cells. For instance, CRISPR technology can be used to engineer T cells to target specific cancer antigens, enhancing the efficacy of immunotherapy.
